Lipids
Lipids(脂质)
- Acyl-CoAs(13)
- Cyclooxygenase(543)
- Endocannabinoid/Endocannabinoid-like(145)
- Fatty Acid Conjugates(11)
- Fatty Acids(498)
- Fatty Alcohols/Aldehydes(16)
- Fatty Amides(77)
- Fatty Esters/Ethers(152)
- Glycerolipids(357)
- Glycerophospholipids(272)
- Hydrocarbons(15)
- Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids(146)
- Isoprostanes(36)
- Leukotrienes(69)
- Lipid Transport(11)
- Lipid-Based Drug Delivery(163)
- Lipoxins/Resolvin Es(10)
- Octadecanoids(124)
- Other Lipid Kinases(2)
- P450
- Polyketides(71)
- Prenol Lipids(19)
- Prostaglandins(483)
- Protein Lipidation(24)
- Reactive O2/N2 Pathways(116)
- Saccharolipids(2)
- Sphingolipids(359)
- Sterol Lipids(288)
- Thromboxanes(14)
- 11β-HSD
- 17β-HSD(2)
Lipids 相关产品(3019)
- GC44072Linoleoyl EthanolamideCAS: 68171-52-8纯度: >98.00%
Linoleoyl Ethanolamide是一种脂肪酸乙醇酰胺，与大麻素受体（CB1和CB2受体）的Ki值分别为10和25μM，可竞争性抑制anandamide水解，并表现出抗过敏和抗炎作用。
- GC44073Linoleoyl Ethanolamide PhosphateCAS: 419566-71-5纯度: >95.00%
An intermediate in the synthesis of linoleoylethanolamide
- GC44077Lithocholic Acid 3-sulfate (sodium salt)CAS: 64936-81-8纯度: >98.00%
A metabolite of lithocholic acid
- GC44101Lyso-Globotriaosylceramide (d18:1)CAS: 126550-86-5纯度: >98.00%
A globotriaosylceramide lacking the fatty acyl group
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC44067 | Linoelaidic Acid methyl ester | 2566-97-4 | >95.00% | |
An esterified form of linoelaidic acid | ||||
| GC44068 | Linoleic Acid (sodium salt) | 822-17-3 | >95.00% | |
An essential ω-6 PUFA | ||||
| GC44069 | Linoleic Acid Amide | 3999-01-7 | >98.00% | |
A primary fatty acid amide | ||||
| GC44071 | Linoleic Acid-biotin | - | >95.00% | |
An affinity probe for linoleic acid binding proteins | ||||
| GC44072 | Linoleoyl Ethanolamide | 68171-52-8 | >98.00% | |
Linoleoyl Ethanolamide是一种脂肪酸乙醇酰胺，与大麻素受体（CB1和CB2受体）的Ki值分别为10和25μM，可竞争性抑制anandamide水解，并表现出抗过敏和抗炎作用。 | ||||
| GC44073 | Linoleoyl Ethanolamide Phosphate | 419566-71-5 | >95.00% | |
An intermediate in the synthesis of linoleoylethanolamide | ||||
| GC44074 | Linoleoyl Glycine | 2764-03-6 | >98.00% | |
A homolog of arachidonyl glycine | ||||
| GC44077 | Lithocholic Acid 3-sulfate (sodium salt) | 64936-81-8 | >98.00% | |
A metabolite of lithocholic acid | ||||
| GC44086 | L-threo Lysosphingomyelin (d18:1) | 105615-55-2 | >98.00% | |
A bioactive sphingolipid | ||||
| GC44087 | L-threo-PPMP (hydrochloride) | - | >98.00% | |
An inhibitor of glucosylceramide synthetase | ||||
| GC44092 | Lumula | 511229-72-4 | >98.00% | |
A hybrid eicosanoid analog | ||||
| GC44099 | Lysodihydrosphingomyelin (d18:0) | - | >98.00% | |
A saturated form of lysosphingomyelin | ||||
| GC44101 | Lyso-Globotriaosylceramide (d18:1) | 126550-86-5 | >98.00% | |
A globotriaosylceramide lacking the fatty acyl group | ||||
| GC44102 | Lyso-Monosialoganglioside GM1 (ammonium salt) | - | >98.00% | |
A sphingolipid | ||||
| GC44103 | Lyso-PAF C-16 | 52691-62-0 | >98.00% | |
A precursor of PAF | ||||
| GC44104 | Lyso-PAF C-18 | 74430-89-0 | >98.00% | |
Deacetylated PAF C-18 | ||||
| GC44105 | Lysosphingomyelin (d18:1) | 1670-26-4 | >98.00% | |
A bioactive sphingolipid | ||||
| GC44138 | MCTR1 | 1784701-61-6 | ≥95% | |
A specialized pro-resolving mediator | ||||
| GC44139 | MCTR2 | 1784701-62-7 | >97.00% | |
A specialized pro-resolving mediator | ||||
| GC44140 | MCTR3 | 1784701-63-8 | >98.00% | |
A specialized pro-resolving mediator | ||||
| GC44180 | Methylcarbamyl PAF C-16 | 91575-58-5 | >98.00% | |
A stable analog of PAF C-16 | ||||
| GC44181 | Methylcarbamyl PAF C-8 | - | >98.00% | |
C-8 analog of Methylcarbamyl PAF C-16 | ||||
| GC44191 | MHY908 | 1393371-39-5 | >98.00% | |
A PPARα and PPARγ dual agonist | ||||
| GC44222 | ML-298 | 1426916-02-0 | >98.00% | |
A selective inhibitor of PLD 2 | ||||